Vycor Medical Current Debt
| VYCO Stock | USD 0.07 0 1.45% |
Vycor Medical has over 150,000 in debt which may indicate that it relies heavily on debt financing. With a high degree of financial leverage come high-interest payments, which usually reduce Vycor Medical's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Vycor Medical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Vycor Medical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the OTC Stock is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Vycor OTC Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Vycor Medical's stakeholders.
For most companies, including Vycor Medical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Vycor Medical, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Vycor Medical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Vycor Medical's debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Vycor Medical is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Vycor Medical to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Vycor Medical is said to be less leveraged. If creditors hold a majority of Vycor Medical's assets, the OTC Stock is said to be highly leveraged.
Vycor |
Vycor Medical Debt to Cash Allocation
Vycor Medical currently holds 150 K in liabilities with Debt to Equity (D/E) ratio of 390.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vycor Medical has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vycor Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Vycor Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vycor Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vycor to invest in growth at high rates of return. When we think about Vycor Medical's use of debt, we should always consider it together with cash and equity.Vycor Medical Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Vycor Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Vycor Medical, which in turn will lower the firm's financial flexibility.Understaning Vycor Medical Use of Financial Leverage
Leverage ratios show Vycor Medical's total debt position, including all outstanding obligations. In simple terms, high financial leverage means that the cost of production, along with the day-to-day running of the business, is high. Conversely, lower financial leverage implies lower fixed cost investment in the business, which is generally considered a good sign by investors. The degree of Vycor Medical's financial leverage can be measured in several ways, including ratios such as the debt-to-equity ratio (total debt / total equity), or the debt ratio (total debt / total assets).
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited. Vycor Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 6 people. Please read more on our technical analysis page.
Pair Trading with Vycor Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vycor Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vycor Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Vycor OTC Stock
| 0.45 | OPTX | Syntec Optics Holdings Trending | PairCorr |
| 0.39 | MMV | MultiMetaVerse Holdings | PairCorr |
| 0.34 | THCPU | Thunder Bridge Capital | PairCorr |
The ability to find closely correlated positions to Vycor Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vycor Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vycor Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vycor Medical to buy it.
The correlation of Vycor Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vycor Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vycor Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vycor Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Vycor OTC Stock
Vycor Medical financial ratios help investors to determine whether Vycor OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vycor with respect to the benefits of owning Vycor Medical security.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.